Table 1:
Patient Demographics.
Variable | PGD, N=7 | GDM, N=6 | Control, N=6 | P value |
---|---|---|---|---|
Age | 30.9±8.1 | 30.7±7.1 | 33.2±5.8 | 0.84 |
Race/Ethnicity | ||||
White | 0 | 0 | 3 | 0.04 |
Black | 2 | 1 | 0 | 0.76 |
Asian | 0 | 1 | 0 | 0.56 |
Hispanic | 4 | 4 | 2 | 0.13 |
Other | 2 | 0 | 1 | 0.21 |
Weight (kg) | 87±17.2 | 89.1±20.4 | 75.6±13.4 | 0.48 |
BMI (m/kg2) | 33.9±4.3 | 33.6±6.6 | 27.6±6.8 | 0.2 |
HgBAIC (%) First Trimester | 9.2±1.7 | 6±0.28 | 5.3±0.17 | 0.0003 |
Second Trimester | 7.3±1.2 | 5.9±0.35 | NA | 0.09 |
Third Trimester | 6.7±0.8 | 6 | NA | 0.48 |
Fasting Plasma Glucose (mg/dL) | 92.4±18.3 | 92±18.3 | 74±12.5 | 0.3 |
75 mg 2 Hour Oral Glucose Tolerance Test Glucose Level (mg/dL) | NA | 170.5±79.9 | 85.5±21.9 | NA |
Medications | ||||
Oral | 2 | 2 | 0 | 0.13 |
Insulin | 6 | 0 | 0 | 0.13 |
Pre-eclampsia | 1 | 0 | 0 | 0.04 |
Gestational Hypertension | 2 | 0 | 0 | 0.47 |
Retinopathy | 0 | 0 | 0 | NA |
Chronic Hypertension | 3 | 0 | 0 | 0.2 |
Nephropathy | 0 | 0 | 0 | NA |